128 Investor — «Mitochondria in Longevity. Switzerland Overview» | Mindmaps

128 Investor
Mitochondria in Longevity. Switzerland Overview

Wellington Partners 1998

Woodford Investment Management 2014-01-01

WuXi AppTec 2000-12-01

« First Previous Page 6 of 6

Mitochondria in Longevity. Switzerland Overview

Organisation

Investor

Hub

Industries

advice, banking, financial services application performance management, business development, finance artificial intelligence, pharmaceutical, robotics, venture capital asset management asset management, finance, venture capital asset management, financial services, management consulting association, health care, medical, non profit banking biomarkers discovery biotechnology biotechnology, consumer, health care, medical device, pharmaceutical biotechnology, finance, health care, venture capital biotechnology, financial services, health care biotechnology, financial services, health care, lending and investments, science and engineering biotechnology, financial services, health care, pharmaceutical biotechnology, financial services, lending and investments, science and engineering biotechnology, genetics, health care, medical biotechnology, health care, hospital, medical, non profit, wellness biotechnology, health care, medical, venture capital biotechnology, health care, pharmaceutical, venture capital biotechnology, health diagnostics, life science, pharmaceutical conflict prevention and stabilization digital biomarkers energetic process finance finance & banking finance, financial services, fintech, life science finance, financial services, health care, venture capital finance, financial services, venture capital financial services financial services, fintech, government financial services, health care, lending and investments financial services, health care, venture capital financial services, lending and investments financial services, venture capital global health health care health care, venture capital health tech healthcare imaging industry agnostic innovation, technology, and research investment funds longevity longevity biomarkers medical biotech mhealth mitochondrial genetics n/a omics omics-based biomarkers other potential investors venture capital wealthtech & asset management

© 2024